Monday, 09 Dec 2019

You are here

RheumNow Week in Review – 22 April 2016

Highlights from this week on RheumNow.com

  1. Systematic review by Felson et al shows that MTX use in current RA clinical trials is suboptimal, most using 15mg, the highest dose was 20mg/wk and only one trial with parenteral MTX.  https://t.co/1DYHxLK2DJ
  2. There's a despirate need for effective DMARD or biologic therapy for patients with with erosive osteoarthritis! GSK announced the launch of its Phase 2 trial of GM-CSF MAb in patients with inflammatory hand OA. https://t.co/cXNdTDufR7
  3. Celltrion chief executive said that Inflectra is expected to be priced ~20-30% lower than Remicade when released in the US. https://t.co/ceCHuYubzK
  4. Perioperative MTX use does not cause increased postoperative infectious complications or sepsis in IBD patients having abdominal surgery. https://t.co/ApgCyEhpeG
  5. A New Look at Old Pictures.  Dr. David Pisetsky blogs on the appropriate or misleading use of picture to educate. 
  6. Do's and Don'ts of Vaccination: a (Very) Brief Guide for Rheumatologists by Dr. Kevin Winthrop.  
  7. Vaccine Success is Limited in Rheumatoid Arthritis.  
  8. α Defensin Control of Inflammation.  The protective effects of defensins and their therapeutic potential is proposed.  
  9. BeST Trial and 10-Year Outcomes of Four Treatment Strategies
  10. Osteoporotic Fractures at Higher Risk for Subsequent Fractures  

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

RheumNow Podcast - Monitoring Methotrexate Safety (12-6-19)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

#WomenInRheumatology: Is There a Speaker Gender Gap at ACR Meetings?

Recent studies have quantified the gender gap among speakers at academic conferences. The largest study of 181 medical conferences held in North America over one decade found an increase in the proportion of female speakers from 25 to 34% over time, and that the underrepresentation of women was more marked at surgical compared to medical conferences.

RheumNow Podcast –Favorites of ACR 2019 (11.22.19)

Dr. Jack Cush recaps standout presentations and information from ACR 2019 held in Atlanta November 9-12, 2019.

Hepatitis C-Related Cryoglobulinemic Vasculitis

Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.

ACR 2019 - Report from Day One (Sunday)

Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day one. 

Delays in Diagnosis